Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line

被引:22
|
作者
Daruhazi, Agnes Emma [1 ]
Kiss, Timea [2 ]
Vecsernyes, Miklos [2 ]
Szente, Lajos [3 ]
Szoke, Eva [1 ]
Lemberkovics, Eva [1 ]
机构
[1] Semmelweis Univ, Dept Pharmacognosy, H-1085 Budapest, Hungary
[2] Univ Debrecen, Dept Pharmaceut Technol, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[3] CycloLab Ltd, H-1097 Budapest, Hungary
关键词
Genistein; Daidzein; Dissolution profile; Caco-2; Cyclodextrin; PHYTOESTROGENS; ISOFLAVONOIDS;
D O I
10.1016/j.jpba.2013.05.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Isoflavonoids are widespread constituents in medical plants especially in legumes (Fabaceae), but occur in other different plant families as well (Rosaceae, Iridaceae, Amaranthaceae). Their antioxidant, estrogen-like, anti-inflammatory and analgesic effects make them promising compounds in therapy of important disorders especially in estrogen related diseases. Poor solubility in aqueous system of genistein and daidzein needs a solubility enhancement for pharmaceutical use. These compounds are suitable guest molecules for inclusion complex formation with cyclodextrins (CDs) considering matching their size and polarity. The molecular encapsulation with beta-cyclodextrin (beta-CD), gamma-cyclodextrin (gamma-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and random methyl-beta cyclodextrin (RAMEB-CD) results in a solid, molecularly dispersed form and in a significantly improved aqueous solubility of genistein and daidzein. Determining enhancement in solubility and bioavailability we investigated the transport of these inclusion complexes across Caco-2 cell line comparing that of the pure compounds and found significant improving effect of the different CD derivatives on membrane permeation of the two isoflavone aglycons. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
  • [1] Transport and metabolism of genistein, daidzein and their glycosides in Caco-2 cells and in perfused gut segments
    Steensma, A
    Noteborn, HPJM
    Mengelers, MJB
    Kuiper, HA
    DIETARY ANTICARCINOGENS AND ANTIMUTAGENS, 2000, (255): : 64 - 68
  • [2] Bioavailability of genistein, daidzein, and their glycosides in intestinal epithelial Caco-2 cells
    Steensma, A
    Noteborn, HPJM
    van der Jagt, RCM
    Polman, THG
    Mengelers, MJB
    Kuiper, HA
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 1999, 7 (03) : 209 - 211
  • [3] Transport of genistein and its 7-glucoside by the human intestinal Caco-2 cell line.
    Walle, T
    Walle, UK
    FASEB JOURNAL, 1999, 13 (05): : A884 - A884
  • [4] Intestinal transport of Cylindrospermopsin using the Caco-2 cell line
    Pichardo, Silvia
    Devesa, Vicenta
    Puerto, Maria
    Velez, Dinoraz
    Camean, Ana M.
    TOXICOLOGY IN VITRO, 2017, 38 : 142 - 149
  • [5] Transcellular transport of genistein, a soybean-derived isoflavone, across human colon carcinoma cell line (Caco-2)
    Oitate, M
    Nakaki, R
    Koyabu, N
    Takanaga, H
    Matsuo, H
    Ohtani, H
    Sawada, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2001, 22 (01) : 23 - 29
  • [6] Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides
    Steensma, A
    Noteborn, HPJM
    Kuiper, HA
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2004, 16 (03) : 131 - 139
  • [7] Transport Characteristics of Candesartan in Human Intestinal Caco-2 Cell Line
    Zhou, Lingjie
    Chen, Xiaoping
    Gu, Yuanqing
    Liang, Jianying
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (05) : 259 - 264
  • [8] Study of intestinal transport of cylindrospermopsin using the Caco-2 cell line
    Camean, A.
    Pichardo, S.
    Puerto, M.
    Devesa, V.
    Velez, D.
    TOXICOLOGY LETTERS, 2016, 258 : S166 - S166
  • [9] Study of intestinal transport of F using Caco-2 cell line
    Devesa, V.
    Rocha, R.
    Montoro, R.
    Velez, D.
    TOXICOLOGY LETTERS, 2010, 196 : S306 - S306
  • [10] ABSORPTION AND METABOLISM OF BIOLOGICALLY ACTIVE GENISTEIN DERIVATIVES IN COLON CARCINOMA CELL LINE (CACO-2)
    Papaj, Katarzyna
    Rusin, Aleksandra
    Szeja, Wieslaw
    Grynkiewicz, Grzegorz
    ACTA POLONIAE PHARMACEUTICA, 2014, 71 (06): : 1037 - 1044